Krebs Biochemicals and Industries has informed that it enclosed copies of the Audited Financial Results for the 4th quarter and financial year ended March 31, 2026 approved in the Board Meeting held on May 21, 2026 and published on May 22, 2026 in Business Standard (English) and Prajasakti (Telugu).
The above information is a part of company’s filings submitted to BSE.